United States · FDA National Drug Code directory
Divalproex Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0378-0472_346235bd-f9cb-4693-9ad2-d62cbe9c62ef
- Product NDC
- 0378-0472
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- divalproex sodium
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090129
- Source listing expiry
- 20271231
Source-listed ingredients
- DIVALPROEX SODIUM — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-0472-01) · 0378-0472-01
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-0472-05) · 0378-0472-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →